DNLI

NASDAQ · Equity

Denali Therapeutics Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
21.040000
Fair value
19.999487
Expectation
Negative 38.65%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
21.04
12-Week Change
2.28%
Trend Signal
Active
Expectation
Negative 38.65%
Signal Weeks
11 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
0.14
Market Dynamics
-0.58

Over the latest 12 completed weeks ending 2026-05-29, DNLI rose 2.28%, moving from 20.57 to 21.04. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 11 of the last 12 weeks. Relative Strength is 0.14 and has softened across the 12-week window. Market Dynamics is -0.58 on the latest week. Expectation is negative at 38.65%.